TE_139
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | AluSx |
|---|---|
| TE superfamily | Alu |
| TE order | SINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 0.32 |
| Counts of samples | TCGA_tumor:181; TCGA_normal:24; GTEx:611 |
| TSS | chr1(-):15760136 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_139.1 | - | Intergenic | Non-coding | Non-coding | chr1(-):15751112,15751132,15756481,15756722,15760006,15760137 |
| teRNA_139.2 | - | Intergenic | Non-coding | Non-coding | chr1(-):15756702,15756722,15757013,15757087,15760006,15760137 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
